相关实验视频

Updated: Jun 26, 2025

Genome-Wide CRISPR Screen for Unveiling Radiosensitive and Radioresistant Genes

Genome-Wide CRISPR Screen for Unveiling Radiosensitive and Radioresistant Genes

Published on: May 23, 2025

克里斯普尔/Cas9查:揭开癌症免疫疗法的"罗塞塔石"

Baoxiang Chen¹, Yanrong Deng², Xianghai Ren²

¹Department of Colorectal and Anal Surgery, Zhongnan Hospital of Wuhan University, Wuhan 430071, China; Hubei Key Laboratory of Intestinal and Colorectal Diseases, Zhongnan Hospital of Wuhan University, Wuhan 430071, China; Clinical Center of Intestinal and Colorectal Diseases of Hubei Province, Zhongnan Hospital of Wuhan University, Wuhan 430071, China; Rosalind and Morris Goodman Cancer Institute, McGill University, Montreal, QC H3G 0B1, Canada.

Trends in molecular medicine

|May 19, 2024

概括

聚类定期间隔的平行体重复 (CRISPR) 查识别了对癌症免疫治疗至关重要的基因和途径. 这项技术推动了针对各种癌症类型的新型免疫治疗点的开发.

科学领域:

生物医学研究的研究.
基因组学就是基因组学.
免疫学免疫学免疫学

背景情况:

基于CRISPR的技术提供了不受偏见的功能性基因组查.
癌症免疫疗法已经彻底改变了癌症治疗.
确定新的点对于提高免疫疗法疗效至关重要.

研究的目的:

审查CRISPR/Cas9查癌症免疫治疗方面的进展.
概述通过CRISPR查识别的免疫治疗标.
根据癌症类型对目标进行分类.

主要方法:

使用CRISPR/CRISPR相关蛋白9 (Cas9) 进行遗传干扰查.
分析查数据以确定关键的基因,生物标志物和途径.
根据癌症类型对已识别的目标进行分类.

主要成果:

克里斯普尔查已经确定了许多调节癌症免疫活性的基因和信号通路.
使用这项技术已经发现了有效的免疫治疗点.
审查将这些目标根据特定的癌症类型进行分类.

结论:

克里斯普尔/卡斯9查是促进癌症免疫治疗的强大工具.
这项技术有助于发现新的治疗点.
这些发现有助于开发更有效和个性化的癌症免疫疗法.

关键词:

通过CRISPR/Cas9查进行查.癌症免疫疗法免疫疗法免疫治疗的目标是免疫疗法.

更多相关视频

Performing an In Vitro Genome-Wide CRISPR Knockout Screen in Chimeric Antigen Receptor T Cells

Performing an In Vitro Genome-Wide CRISPR Knockout Screen in Chimeric Antigen Receptor T Cells

Published on: January 31, 2025

Evaluation of Abnormal Growth-related Genes of Hematopoietic Stem and Progenitor Cells by Combining CRISPR/Cas9 Technology with Cell Counting

Evaluation of Abnormal Growth-related Genes of Hematopoietic Stem and Progenitor Cells by Combining CRISPR/Cas9 Technology with Cell Counting

Published on: May 2, 2025

相关概念视频

CRISPR

CRISPR

Genome editing technologies allow scientists to modify an organism’s DNA via the addition, removal, or rearrangement of genetic material at specific genomic locations. These types of techniques could potentially be used to cure genetic disorders such as hemophilia and sickle cell anemia. One popular and widely used DNA-editing research tool that could lead to safe and effective cures for genetic disorders is the CRISPR-Cas9 system. CRISPR-Cas9 stands for Clustered Regularly Interspaced...

CRISPR and crRNAs

CRISPR and crRNAs

Bacteria and archaea are susceptible to viral infections just like eukaryotes; therefore, they have developed a unique adaptive immune system to protect themselves. Clustered regularly interspaced short palindromic repeats and CRISPR-associated proteins (CRISPR-Cas) are present in more than 45% of known bacteria and 90% of known archaea.
The CRISPR-Cas system stores a copy of foreign DNA in the host genome and uses it to identify the foreign DNA upon reinfection. CRISPR-Cas has three different...

Tumor Immunotherapy

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.

Homologous Recombination

Homologous Recombination

The basic reaction of homologous recombination (HR) involves two chromatids that contain DNA sequences sharing a significant stretch of identity. One of these sequences uses a strand from another as a template to synthesize DNA in an enzyme-catalyzed reaction. The final product is a novel amalgamation of the two substrates. To ensure an accurate recombination of sequences, HR is restricted to the S and G2 phases of the cell cycle. At these stages, the DNA has been replicated already and the...

Combination Therapies and Personalized Medicine

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...